Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects

Rifabutin (RFB) is administered for treatment of tuberculosis and Mycobacterium avium complex infection, including use for patients coinfected with human immunodeficiency virus (HIV). Increased systemic exposure to RFB and its equipotent active metabolite, 25-O-desacetyl-RFB (dAc-RFB), has been repo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ford, Susan L., Chen, Ya-Chi, Lou, Yu, Borland, Julie, Min, Sherene S., Yuen, Geoffrey J., Shelton, Mark J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 2008
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2224730/
https://ncbi.nlm.nih.gov/pubmed/18056271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00724-07
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak